You must be new to investing in companies that are still relatively young, OTC and biotechs in general. Sale`s are not a fair indicator for a company like ONVO that is mainly in R&D phases of their technology. You have to look at their prospects, potential market and partnerships. All of which ONVO excels at.
Financially, take a look at their newly cleaned up balance sheet and cashflow. No more warrant liabilities as they all got converted into cash and equity. Where is the need for dilution?
If you're not a short, I'll be glad to educate you further. Otherwise, good luck with the pump & dump theory.